Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Voso

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Blood|July 11, 2000
Microchimerism in bone marrow-derived CD34(+) cells of patients after liver transplantationD Nierhoff, H C Horvath, J Mytilineos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasS Hohaus, M Giachelia, G Massini, et al.
International Journal of Cancer|October 23, 1997
Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70L M Larocca, F O Ranelletti, N Maggiano, et al.
British Journal of Cancer|October 19, 2006
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemiaA Scardocci, F Guidi, F D'Alo', et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphomaS Hohaus, M Giachelia, A Di Febo, et al.
Neurology|February 25, 2011
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genesS K Hasan, F Buttari, T Ottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
Leukemia|November 7, 2013
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidineA Valencia, E Masala, A Rossi, et al.
Leukemia Research|November 11, 2011
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemiaT Ottone, L Cicconi, S K Hasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective studyM T Voso, G Leone, A Piciocchi, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Blood|July 11, 2000
Microchimerism in bone marrow-derived CD34(+) cells of patients after liver transplantationD Nierhoff, H C Horvath, J Mytilineos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasS Hohaus, M Giachelia, G Massini, et al.
International Journal of Cancer|October 23, 1997
Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70L M Larocca, F O Ranelletti, N Maggiano, et al.
British Journal of Cancer|October 19, 2006
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemiaA Scardocci, F Guidi, F D'Alo', et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphomaS Hohaus, M Giachelia, A Di Febo, et al.
Neurology|February 25, 2011
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genesS K Hasan, F Buttari, T Ottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
Leukemia|November 7, 2013
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidineA Valencia, E Masala, A Rossi, et al.
Leukemia Research|November 11, 2011
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemiaT Ottone, L Cicconi, S K Hasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective studyM T Voso, G Leone, A Piciocchi, et al.
Pageof 6